Aandeel BHC BAUSCH HEALTH COMPANIES INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Bausch Health Companies Inc.

Aandelen

BHC

CA0717341071

Beurs gesloten - Nyse
Andere beurzen
 22:00:01 18-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8,6 USD -0,69% Intraday-grafiek van Bausch Health Companies Inc. -4,12% +7,23%
12/04 Bausch Health krijgt "positieve" uitspraak van rechtbank over Xifaxan met marktkansen op Bausch + Lomb distributie op 32%, zegt RBC MT
11/04 Bausch wint beroep in VS om generiek geneesmiddel tegen diarree van Alvogen te blokkeren RE

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Bausch Health Gets 'Positive' Court Ruling on Xifaxan With Market Odds of Bausch + Lomb Distribution at 32%, RBC Says
RBC Notes "Positive" Appellate Court Ruling For Bausch Health, But Thinks Market Assigning ~32% BLCO Distribution Odds
Bausch Health, Canada Inc. - Acne vulgaris treatment PrARAZLO now available to patients through British Columbia PharmaCare public drug plan
Bausch Health Companies - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
Bausch Health to Announce First-Quarter 2024 Results on May 2
Bausch wins US appeal to block Alvogen generic of diarrhea drug
Canadian Investment Regulatory Organization Trade Resumption - BHC
Canadian Investment Regulatory Organization Trading Halt - BHC
Bausch Health, Canada Inc. Announces Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
Bausch Health Up Near 0.4% In US Premarket After Announcing Patent Lawsuit Against Amneal Pharmaceuticals
North American Morning Briefing : Inflation Data, -2-
Trump eyes $43 million haul from biggest fundraiser yet
RBC Raises Bausch Health Target to US$12, Maintains Sector Perform, on Upcoming Xifaxan Litigation Ruling
/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/
Canadian Investment Regulatory Organization Trade Resumption - BHC
Bausch Health - Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for Uceris Aerosol Foam
Bausch Health Brief: Bausch Health, Canada Inc. Announcing First Public Drug Plan Listings for UCERIS Aerosol Foam
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers BHC
  4. Nieuws Bausch Health Companies Inc.
  5. Andere talen